Required for Advisory Committee for Borderline Substances (ACBS) approval. Aim of this study is to access the palatability, compliance and GI-tolerance of Nutricomp® Drink Plus Fibre to show that it is acceptable for patients in the United Kingdom.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
19
AC Health & Nutrition Ltd
Leigh-on-Sea, United Kingdom
Occurrence of gastrointestinal tolerance parameters
Time frame: Day 1 - day 13
Occurrence of (further) adverse events during the treatment period (yes/no, if yes timing/duration/assumed cause/seriousness/severity)
Time frame: Day 1 - day 13
Palatability evaluation performed under controlled condition using a questionnaire with a 5 point hedonic scale rang
Time frame: Day 1 - day 13
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.